p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

Wales, Michele Makos, Biel, Margaret A., Deiry, Wafik El, Nelkin, Barry D., Issa, Jean-Pierre, Cavenee, Webster K., Kuerbitz, Steven J., Baylin, Stephen B.·1995·Nature Medicine

DOI 10.1038/nm0695-570

Cited by (420)

Items 101–200 of 420

HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors
Capucine Van Rechem, Majid Touka, Gaylor Boulay, Cateline Guérardel, Brian R. Rood, Dominique Leprince · 2008 · The International Journal of Biochemistry & Cell Biology
Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
Yoshio Tomizawa, Takashi Kohno, Takeshi Fujita, Masaharu Kiyama, Ryusei Saito, Masayuki Noguchi, Yoshihiro Matsuno, Setsuo Hirohashi, Naohito Yamaguchi, Takashi Nakajima et al. · 1999 · Oncogene
HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk
Yingying Wang, Xiaoling Weng, Luoyang Wang, Mingang Hao, Yue Li, Lidan Hou, Yu Liang, Tianqi Wu, Mengfei Yao, Guowen Lin et al. · 2018 · Journal of Clinical Investigation
ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma
Silke Götze, Valeska Feldhaus, Thilo Traska, Marietta Wolter, Guido Reifenberger, Andrea Tannapfel, Cornelius Kuhnen, Dirk Martin, Oliver Müller, Sonja Sievers · 2009 · BMC Cancer
Zwitterion-functionalized dendrimer-entrapped gold nanoparticles for serum-enhanced gene delivery to inhibit cancer cell metastasis
Zhijuan Xiong, Carla S. Alves, Jianhua Wang, Aijun Li, Jinyuan Liu, Mingwu Shen, João Rodrigues, Helena Tomás, Xiangyang Shi · 2019 · Acta Biomaterialia
Systems Analysis of Immune Responses in Marek's Disease Virus-Infected Chickens Identifies a Gene Involved in Susceptibility and Highlights a Possible Novel Pathogenicity Mechanism
Jacqueline Smith, Jean-Rémy Sadeyen, Ian R. Paton, P.M. Hocking, Nigel Salmon, Mark S. Fife, Venugopal Nair, David W. Burt, Pete Kaiser · 2011 · Journal of Virology
Arsenic-Related Chromosomal Alterations in Bladder Cancer
L. E. Moore · 2002 · JNCI Journal of the National Cancer Institute
Integration of a growth‐suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor
Susana de la Luna, K.Elizabeth Allen, Sarah L. Mason, Nicholas Barrie La Thangue · 1999 · The EMBO Journal
The Tumor Suppressor Gene HIC1 (Hypermethylated in Cancer 1) Is a Sequence-specific Transcriptional Repressor
Sébastien Pinte, Nicolas Stankovic‐Valentin, Sophie Deltour, Brian R. Rood, Cateline Guérardel, Dominique Leprince · 2004 · Journal of Biological Chemistry
The DNA methylation machinery as a target for anticancer therapy
Moshe Szyf A · 1996 · Pharmacology & Therapeutics
Loss of heterozygosity analysis: Practically and conceptually flawed?
Ian P.M. Tomlinson, Maryou B. K. Lambros, Rebecca R. Roylance, Anne‐Marie Cleton-Jansen · 2002 · Genes Chromosomes and Cancer
Aberrant DNA Methylation on Chromosome 16 Is an Early Event in Hepatocarcinogenesis
Yae Kanai, Saori Ushijima, Hitoshi Tsuda, Michiie Sakamoto, Takashi Sugimura, Setsuo Hirohashi · 1996 · Japanese Journal of Cancer Research
DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer
Tiantian Cui, Y Chen, Linlin Yang, Thomas Knösel, Kristin Zöller, Otmar Huber, Iver Petersen · 2011 · British Journal of Cancer
Alterations of DNA methylation and clinicopathological diversity of human cancers
Yae Kanai · 2008 · Pathology International
DNA hypomethylation in breast cancer: An independent parameter of tumor progression?
Jacqueline Bernardino-Sgherri, C. Roux, A. Almeida, Nicolas Vogt, Anne Gibaud, Michèle Gerbault‐Seureau, H Magdelénat, Claire A. Bourgeois, Bernard Malfoy, Bernard Dutrillaux · 1997 · Cancer Genetics and Cytogenetics
Role of the Insulin-like Growth Factor System in Adrenocortical Growth Control and Carcinogenesis
C. Fottner, Andreas Hoeflich, Eckhard Wolf, M. Weber · 2004 · Hormone and Metabolic Research
A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice
Irina Kholodnyuk, Marija Kost‐Alimova, Vladimir I. Kashuba, Rinat Z. Gizatullin, Anna Szeles, Eric J. Stanbridge, Eugene R. Zabarovsky, George Klein, Stephan Imreh · 1997 · Genes Chromosomes and Cancer
Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development
Liping Hu, Yiwei Tony Zhu, Chao Qi, Yi-Jun Zhu · 2009 · Cancer Research
Identification in the Human Candidate Tumor Suppressor GeneHIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53
Cateline Guérardel, Sophie Deltour, Sébastien Pinte, Didier Monté, Agnès Begue, Andrew K. Godwin, Dominique Leprince · 2001 · Journal of Biological Chemistry
Genetic alterations distinguish different types of ovarian tumors
Maura Pieretti, Cristina Cavalieri, Pamela S. Conway, Holly H. Gallion, Deborah E. Powell, Mitchell S. Turker · 1995 · International Journal of Cancer
Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm
Elisabetta Ferretti, Enrico De Smaele, Lucia Di Marcotullio, Isabella Screpanti, Alberto Gulino · 2005 · Trends in Molecular Medicine
Scavenger Chemokine (CXC Motif) Receptor 7 (CXCR7) Is a Direct Target Gene of HIC1 (Hypermethylated in Cancer 1)
Capucine Van Rechem, Brian R. Rood, Majid Touka, Sébastien Pinte, Mathias Jenal, Cateline Guérardel, Keri M. Ramsey, Didier Monté, Agnès Begue, Mario P. Tschan et al. · 2009 · Journal of Biological Chemistry
Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection
Makoto Suzuki, Shinichi Toyooka, Narayan Shivapurkar, Hisayuki Shigematsu, Kuniharu Miyajima, Takao Takahashi, Victor Stastny, Andrea L. Zern, Takehiko Fujisawa, Harvey Ira Pass et al. · 2004 · Oncogene · Retracted
Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer
Asta Försti, Jari Louhelainen, Magnus P. Söderberg, Hans Wijkström, Kari Hemminki · 2001 · European Journal of Cancer
Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: Identification of genetic indicators to predict patient outcome
Hiroto Katoh, Tatsuhiro Shibata, Akiko Kokubu, Hidenori Ojima, Panayiotis Loukopoulos, Yae Kanai, Tomoo Kosuge, Masashi Fukayama, Tadashi Kondo, Michiie Sakamoto et al. · 2005 · Journal of Hepatology
Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci
Olivier Albagli, Danièle Lantoine, Sabine Quief, Frédérique Quignon, Christoph Englert, Jean‐Pierre Kerckaert, Didier Montarras, Christian Pinset, Catherine Lindon · 1999 · Oncogene
Epigenetic Silencing of theHIC-1Gene in Human Medulloblastomas
Anke Waha, Andreas Waha, Arend Koch, Birgit Meyer‐Puttlitz, Sascha Weggen, N. Sörensen, Jörg C. Tonn, Steffen Albrecht, Cynthia G. Goodyer, Frank Berthold et al. · 2003 · Journal of Neuropathology & Experimental Neurology
Analysis of HIC‐1 methylation and transcription in human ependymomas
Anke Waha, Arend Koch, Wolfgang Hartmann, Heike Mack, Johannes Schramm, Niels Schwartz Sørensen, Frank Berthold, Otmar Dieter Wiestler, Torsten Pietsch, Andreas Waha · 2004 · International Journal of Cancer
Gene amplification is a relatively frequent event leading to ZBTB7A ( Pokemon ) overexpression in non‐small cell lung cancer
Kalliopi Apostolopoulou, Ioannis S. Pateras, Kostas Evangelou, Petros K. Tsantoulis, Michalis Liontos, Christos N. Kittas, D. Tiniakos, Athanassios Kotsinas, Carlos Cordon‐Cardo, Vassilis G. Gorgoulis · 2007 · The Journal of Pathology
Genome-epigenome interactions in cancer.
R. M. Brena, J. Costello · 2007 · Human Molecular Genetics
Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix
Anne-Marie F. van der Kevie-Kersemaekers, J. Hermans, GJ Fleuren, Marc J. van de Vijver · 1998 · British Journal of Cancer
The conserved NAD(H)-dependent corepressor CTBP-1 regulates Caenorhabditis elegans life span
Shuzhen Chen, Johnathan R. Whetstine, Salil K Ghosh, John A. Hanover, Reddy R. Gali, Paul Grosu, Yang Shi · 2009 · Proceedings of the National Academy of Sciences
Regulation of Active DNA Demethylation through RAR-Mediated Recruitment of a TET/TDG Complex
Haider M. Hassan, Bart Kolendowski, Majdina Isovic, Kerstin Böse, Helen J. Dranse, Arthur V. Sampaio, T. Michael Underhill, Joseph Torchia · 2017 · Cell Reports
Ambivalent role of BCL6 in cell survival and transformation
Olivier Albagli · 2003 · Oncogene
Global and Gene-Specific Methylation Patterns in Cancer: Aspects of Tumor Biology and Clinical Potential
Michael Christoph Frühwald, Christoph Plass · 2002 · Molecular Genetics and Metabolism
Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers
Eriko Tokunaga, Yoshihiko Maehara, Eiji Oki, Kaoru Kitamura, Yoshihiro Kakeji, Shinji Ohno, Keizō Sugimachi · 2000 · Cancer Letters
Epigenomics of human colon cancer
F. Javier Carmona, Manel Esteller · 2010 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
Anticancer Agents Targeted to Sirtuins
Tomohiro Kozako, Takayoshi Suzuki, Makoto Yoshimitsu, Naomichi Arima, Shin‐ichiro Honda, Shinji Soeda · 2014 · Molecules
HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification
Jianghua Zheng, Jinglong Wang, Xueqing Sun, Mingang Hao, Tao Ding, Dan Xiong, Xiumin Wang, Yu Zhu, Gang Xiao, Guangcun Cheng et al. · 2013 · Clinical Cancer Research
p53 mutations in urinary bladder cancer
Petra Berggren, Gunnar Steineck, Jan Adolfsson, Johan Hansson, OLOF T. JANSSON, Per Larsson, Bengt Sandstedt, Hans Wijkström, Kari Hemminki · 2001 · British Journal of Cancer
Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
Sabina Solinas‐Toldo, Stefan Lampel, Stephan Stilgenbauer, Jeremy Nickolenko, Axel Benner, Hartmut Döhner, Thomas John Cremer, Peter Lichter · 1997 · Genes Chromosomes and Cancer
Aberrant Gene Silencing in Tumor Progression: Implications for Control of Cancer
Stephen B. Baylin, Wenyong Chen · 2005 · Cold Spring Harbor Symposia on Quantitative Biology
Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis
Aissam El Aliani, Hassan El‐Abid, Yassine El Mallali, Mohammed Attaleb, Moulay Mustapha Ennaji, Mohammed El Mzibri · 2021 · Cancer Epidemiology Biomarkers & Prevention
Targeted Disruption of the 3p12 Gene, Dutt1/Robo1 , Predisposes Mice to Lung Adenocarcinomas and Lymphomas with Methylation of the Gene Promoter
Jian Xian, Alan Aitchison, Linda Bobrow, Gerard Corbett, Richard Pannell, Terence Howard Rabbitts, Pamela H. Rabbitts · 2004 · Cancer Research
Extensive Methylation Is Associated with β-Catenin Mutations in Hepatocellular Carcinoma: Evidence for Two Distinct Pathways of Human Hepatocarcinogenesis
Naoshi Nishida, Takafumi Nishimura, Takeshi Nagasaka, Iwao Ikai, Ajay Goel, Clement Richard Boland · 2007 · Cancer Research
DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis
Yae Kanai, Saori Ushijima, Atsushi Ochiai, Keisuke Eguchi, Ai-Min Hui, Setsuo Hirohashi · 1998 · Cancer Letters
Hypermethylated in Cancer 1 (HIC1) Recruits Polycomb Repressive Complex 2 (PRC2) to a Subset of Its Target Genes through Interaction with Human Polycomb-like (hPCL) Proteins
Gaylor Boulay, Marion Dubuissez, Capucine Van Rechem, Antoine Forget, Kristian Helin, Olivier Ayrault, Dominique Leprince · 2012 · Journal of Biological Chemistry
The role of DNA hypermethylation in human neoplasia
Minoru Toyota, Jean‐Pierre J. Issa · 2000 · Electrophoresis
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial–mesenchymal transition
Steven Hsesheng Lin, Jing Wang, Pierre Saintigny, Chia-Chin Wu, Uma P. Giri, Jing Zhang, Toshi Menju, Lixia Diao, Lauren A. Byers, John N. Weinstein et al. · 2014 · BMC Genomics
Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.
Christiane Klebig, Susanne Seitz, Wolfgang Arnold, Nicole Deutschmann, Manuela Pacyna-Gengelbach, Siegfried Scherneck, Iver Petersen · 2005 · PubMed
Hypermethylated in cancer 1 (HIC1) mediates high glucose induced ROS accumulation in renal tubular epithelial cells by epigenetically repressing SIRT1 transcription
Sheng Zeng, Xiaoyan Wu, Xuyang Chen, Huihui Xu, Tao Zhang, Yong Xu · 2018 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Aberrant promoter CpG methylation and its translational applications in breast cancer
Tingxiu Xiang, Ying Yuan, Lili Li, Zhaohui Wang, Liang-Ying Dan, Yan Chen, Guo-Sheng Ren, Qian Tao · 2011 · 癌症：英文版
Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Sun Hoe Koo, Chun Hwa Ihm, Kye Chul Kwon, Jong Woo Park, Jin‐Man Kim, Gu Kong · 2001 · Cancer Genetics and Cytogenetics
Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms.
Asha Rathi, Arvind K. Virmani, Kenichi Harada, Charles Franklin Timmons, Kuniharu Miyajima, Robert J. Hay, Domenico Mastrangelo, Anirban Maitra, Gail Elizabeth Tomlinson, Adi F. Gazdar · 2003 · PubMed
Tumour‐suppressor genes in prostatic oncogenesis: a positional approach
Robert Bookstein, G. Steven Bova, Donal MacGrogan, Alina Levy, William B. Isaacs · 1997 · British Journal of Urology
CpG-island methylation study of liver fluke-related cholangiocarcinoma
Ruethairat Sriraksa, C Zeller, Mona A El-Bahrawy, Wei Dai, Jureerut Daduang, Patcharee Jearanaikoon, Siri Chau‐in, Robert Eldon Brown, Temduang Limpaiboon · 2011 · British Journal of Cancer
Nuclear import of the BTB/POZ transcriptional regulator Kaiso
Kevin F. Kelly, Abena A. Otchere, Monica Graham, Juliet M. Daniel · 2004 · Journal of Cell Science
HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A
Capucine Van Rechem, Gaylor Boulay, Dominique Leprince · 2009 · Biochemical and Biophysical Research Communications
Isolation and Embryonic Expression of the Novel Mouse Gene Hic1, the Homologue of HIC1, a Candidate Gene for the Miller-Dieker Syndrome
Christina Grimm, Ralf Spörle, Thomas Ernst Schmid, I.‐D. Adler, Jerzy Adamski, Klaus Schughart, Jochen Graw · 1999 · Human Molecular Genetics
PATHOGENESIS OF ADRENOCORTICAL INCIDENTALOMAS AND GENETIC SYNDROMES ASSOCIATED WITH ADRENOCORTICAL NEOPLASMS
Christine Gicquel, Jerome Yves Bertherat, Yves Le Bouc, XAVIER Y. BERTAGNA · 2000 · Endocrinology and Metabolism Clinics of North America
Protected from the inside: Endogenous histone deacetylase inhibitors and the road to cancer
Lucia Di Marcotullio, Gianluca Canettieri, Paola Infante, Azzura Greco, Alberto Gulino · 2011 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial–mesenchymal transition in cancer cells
Jalal Choupani, Sima Mansoori Derakhshan, Sahar Bayat, Mohammad Reza Alivand, Mahmoud Shekari Khaniani · 2017 · Journal of Cellular Physiology
Characterization of γ-Aminobutyric Acid Type A Receptor–Associated Protein, a Novel Tumor Suppressor, Showing Reduced Expression in Breast Cancer
Christiane Klebig, Susanne Seitz, Wolfgang Arnold, Nicole Deutschmann, Manuela Pacyna-Gengelbach, Siegfried Scherneck, Iver Petersen · 2005 · Cancer Research
Hypermethylation of Chromosome 17P Locust D17S5 in Human Prostate Tissue
Ronald A. Morton, John J. Watkins, G. Steven Bova, M Makos, Stephen B. Baylin, William B. Isaacs · 1996 · The Journal of Urology
New insights into p53 protein stabilisation in oral squamous cell carcinoma
Maxine Partridge, S Kiguwa, Gracy Emilion, Stelios Pateromichelakis, Roger A’Hern, John Langdon · 1999 · Oral Oncology
Emerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
J. Xiong · 2012 · Current Molecular Medicine
Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1
Christian Britschgi, Mattia Rizzi, Tobias J. Grob, Mario P. Tschan, Barbara Hügli, Venkateshwar A. Reddy, A.‐C. Andres, Bruce Edward Torbett, A Tobler, Martin F. Fey · 2005 · Oncogene
Developmentally Programmed 3′ CpG Island Methylation Confers Tissue- and Cell-Type-Specific Transcriptional Activation
Yu, Da-Hai, Ware, Carol, Waterland, Robert A., Zhang, Jiexin, Chen, Miao-Hsueh, Gadkari, Manasi, Kunde-Ramamoorthy, Govindarajan, Nosavanh, Lagina M., Shen, Lanlan · 2013 · Molecular and Cellular Biology
DNA Double-strand Breaks Lead to Activation of Hypermethylated in Cancer 1 (HIC1) by SUMOylation to Regulate DNA Repair
Vanessa Dehennaut, Ingrid Loison, Marion Dubuissez, Joe Nassour, Corinne Abbadie, Dominique Leprince · 2013 · Journal of Biological Chemistry
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma
Maria Teresa Di Martino, Pietro Hiram Guzzi, Daniele Caracciolo, Luca Agnelli, Antonino Neri, Brian A. Walker, Gareth John Morgan, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri · 2015 · Oncotarget
Maternal Genes and Facial Clefts in Offspring: A Comprehensive Search for Genetic Associations in Two Population-Based Cleft Studies from Scandinavia
Astanand Jugessur, Min Shi, Håkon Kristian Gjessing, Rolv Terje Lie, Allen James Wilcox, Clarice Ring Weinberg, Kaare Christensen, Abee Lowman Boyles, Sandra Daack‐Hirsch, Truc Trung Nguyen et al. · 2010 · PLoS ONE
High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China
Jing Ze Huang · 2000 · Carcinogenesis
Hypermethylated in Cancer 1 (HIC1), a Tumor Suppressor Gene Epigenetically Deregulated in Hyperparathyroid Tumors by Histone H3 Lysine Modification
Jessica Svedlund, Edblom S. Koskinen, Víctor E. Márquez, Göran Åkerström, Peyman Björklund, Gunnar Westin · 2012 · The Journal of Clinical Endocrinology & Metabolism
A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1
Wei Zhang, Xiaobei Zeng, K. Briggs, Robert M. Beaty, Brian Wesley Simons, R-W Chiu Yen, M A Tyler, H-C Tsai, Y Ye, Gregory S. Gesell et al. · 2010 · Oncogene
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
Nancy J. Phillips, Michelle R. Ziegler, Larry L. Deaven · 1996 · Cancer Letters
Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality
M. Sankar, Kazuaki Tanaka, TS Kumaravel, M Arif, T Shintani, Shigeaki Yagi, Taiichi Kyo, Hiroo Dohy, N Kamada · 1998 · Leukemia
Insights into regulators of p53 acetylation
Nagasaka, Mai, Miyajima, Chiharu, Aoki, Hiromasa, Aoyama, Mineyoshi, Morishita, Daisuke, Inoue, Yasumichi, Hayashi, Hidetoshi · 2022 · Cells
Chordoma Characterization of Significant Changes of the DNA Methylation Pattern
Beate Rinner, Andreas Weinhaeusel, Birgit Lohberger, Elke Verena Froehlich, Walter Pulverer, Carina Fischer, Katharina Meditz, Susanne Scheipl, Slave Trajanoski, Christian Guelly et al. · 2013 · PLoS ONE
Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors
Abdel Hady A. Abdel Wahab, Hatem A. El‐mezayen, Hayaat Sharad, Shaimaa Abdel Rahman · 2011 · Tumor Biology
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females
Nisreen Al‐Moghrabi, Asmaa Nofel, Nujoud Al‐Yousef, Safia Madkhali, Suad M. Bin Amer, Ayodele A. Alaiya, Zakia Shinwari, Taher Al‐Tweigeri, Bedri Karakas, Asma M. Tulbah et al. · 2014 · BMC Cancer
The transcriptional repressor HIC1 regulates intestinal immune homeostasis
Kyle Burrows, Frann Antignano, Michael Bramhall, Alistair Chenery, Sebastian Scheer, Vladimír Kořínek, T. Michael Underhill, Colby Zaph · 2017 · Mucosal Immunology
Insights into phenotypic and functional CD8 + TRM heterogeneity
Maximilian Heeg, Ananda W. Goldrath · 2023 · Immunological Reviews
FBXW11 contributes to stem-cell-like features and liver metastasis through regulating HIC1-mediated SIRT1 transcription in colorectal cancer
Jing Yao, H. J. Yang, Zhe Yang, Xinping Wang, Tong Yang, Bing Ji, Zheng-Yun Zhang · 2021 · Cell Death and Disease
Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer
Gavin Nicoll, D.N. Crichton, H E McDowell, Neil Kernohan, Ted R. Hupp, Alastair Mark Thompson · 2001 · British Journal of Cancer
Effects of Ca++ mobilization on expression of androgen-regulated genes: Interference with androgen receptor-mediated transactivation by AP-1 proteins
Patricia E. Murtha, Wen Bo Zhu, Jianye Zhang, Shaobo Zhang, Charles Y.F. Young · 1997 · The Prostate
Human SIRT1: A potential biomarker for tumorigenesis?
Chang‐Su Lim · 2006 · Cell Biology International
IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation
Yuan Chen, Tiantian Cui, Thomas Knösel, Linlin Yang, Kristin Zöller, Iver Petersen · 2010 · Lung Cancer
Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine
Soo Hyung Ryu, Myoung Kuk Jang, Woo Jean Kim, Danbi Lee, Young–Hwa Chung · 2014 · Cancer and Metastasis Reviews
Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics
Brian R. Rood, Dominique Leprince · 2013 · Expert Opinion on Therapeutic Targets
Promoter Hypermethylation--Can This Change Alone Ever Designate True Tumor Suppressor Gene Function?
S B Baylin, James Gordon Herman · 2001 · JNCI Journal of the National Cancer Institute
Molecular alterations in sporadic breast cancer
F. Lerebours, Rosette Lidereau · 2002 · Critical Reviews in Oncology/Hematology
The Important Molecular Markers on Chromosome 17 and Their Clinical Impact in Breast Cancer
Wei Zhang, Yingyan Yu · 2011 · International Journal of Molecular Sciences
A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer
Jialou Zhu, Zhimao Jiang, Fei Gao, Xueda Hu, Liang Zhou, Jiahao Chen, Huijuan Luo, Jihua Sun, Song Wu, Yonghua Han et al. · 2011 · PLoS ONE
Promoter CpG Island Methylation Markers in Colorectal Cancer: The Road Ahead
Muriel X.G. Draht, Robert G. Riedl, Hanneke E.C. Niessen, Beatriz G. Carvalho, Gerrit A. Meijer, James Gordon Herman, Manon van Engeland, Veerle Melotte, Kim M. Smits · 2012 · Epigenomics
P53-responsive genes and the potential for cancer diagnostics and therapeutics development
Hao Ying Xu, Mohamed Raafat El-Gewely · 2001 · Biotechnology annual review
Comprehensive allelotyping of well‐differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss
Takafumi Nishimura, Naoshi Nishida, Teruaki Itoh, Masato Kuno, Mutsuko Minata, Toshiki Komeda, Yoshihiro Fukuda, Iwao Ikai, Yoshio Yamaoka, Kazuwa Nakao · 2002 · Genes Chromosomes and Cancer
Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer
Hiroyuki Konishi, Miyabi Sugiyama, Kotaro Mizuno, Hiroko Saito, Yasushi Yatabe, Toshitada Takahashi, Hirotaka Osada, Takashi Takahashi · 2003 · Oncogene
The Human GeneZFP161on 18p11.21–pter Encodes a Putativec-mycRepressor and Is Homologous to MurineZfp161(Chr 17) andZfp161-rs1(X Chr)
Ingeborg Sobek-Klocke, Claudia Disqué-Kochem, Melanie Ronsiek, Rainer Klocke, Harald Jockusch, Astrid Breuning, Herwig Ponstingl, Katherine Rojas, Joan Overhauser, Ursula Eichenlaub-Ritter · 1997 · Genomics
Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
A Hügel, Nicolas Wernert · 1999 · British Journal of Cancer
Multigene Methylation Analysis of Gastrointestinal Tumors
Silvia Sabbioni, Elena Miotto, Angelo Veronese, Elisa Sattin, Laura Gramantieri, Luigi Bolondi, George A. Colin, Roberta Gaá, Giovanni Lanza, Giuliano Carli et al. · 2003 · Molecular Diagnosis